Urine test could track chemo effects in colorectal cancer
NCT ID NCT01693861
First seen Jan 06, 2026 · Last updated May 22, 2026 · Updated 17 times
Summary
This study tested whether special sensors could measure changes in urine chemicals to monitor how well chemotherapy is working in people with metastatic colorectal cancer. Sixteen participants provided daily urine samples before and after starting chemotherapy. The goal was to see if these non-invasive urine tests could track cancer activity without needing frequent scans or blood draws.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Paul Brousse Hospital
Villejuif, 94807, France
Conditions
Explore the condition pages connected to this study.